Canopy Growth (TSE:WEED – Get Free Report) had its price target lifted by equities research analysts at TD Securities from C$0.70 to C$1.80 in a research note issued to investors on Friday, BayStreet.CA reports. TD Securities’ price objective would indicate a potential downside of 1.64% from the company’s previous close.
A number of other analysts also recently commented on the stock. Bank of America dropped their price target on shares of Canopy Growth from C$1.00 to C$0.85 in a research report on Thursday, June 15th. Jefferies Financial Group dropped their target price on shares of Canopy Growth from C$0.61 to C$0.59 in a research report on Wednesday, August 16th. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of C$2.02.
View Our Latest Stock Analysis on WEED
Canopy Growth Trading Up 7.6 %
Canopy Growth Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.
Read More
- Five stocks we like better than Canopy Growth
- What is a Non-Fungible Token (NFT)? Definition and How it Works
- 5 Reasons Apple’s New Phone Moves the Needle: 5 That It Won’t
- P/E Ratio Calculation: How to Assess Stocks
- MarketBeat Week in Review – 9/11 – 9/15
- Insider Trading – What You Need to Know
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.